Concepedia

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

Claudio Viscoli, Raoul Herbrecht, Hamdi Akan, Liliana Baila, A. Sonet, Andrea Gallamini, Aristoteles Giagounidis, Oscar Marchetti, Rodrigo Martino, Liv Meert,

Journal of Antimicrobial Chemotherapy · 2009 · 153 citations · 14 references

DOIFull text

Open access

Abstract

Caspofungin provided an observed response rate compatible with the null hypothesis of a true response rate of < or =35%. Underlying disease-related factors had a major impact on results.

References

14

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

John Rex, Ben de Pauw, John E. Bennett et al. · Clinical Infectious Diseases · 2002 · 2.3K citations · Full text

, , +16

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Livio Pagano, Morena Caira, Anna Candoni et al. · PubMed · 2006 · 908 citations

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

David W. Denning, Patricia Ribaud, Nöel Milpied et al. · Clinical Infectious Diseases · 2002 · 842 citations · Full text

, , +7